PFE · News · 20260902N

Revenue Performance and Mix

PFIZER INC · 2026-09-02 · Importance 41 · Surprise 32

Pfizer reported second-quarter 2026 revenue of $15.03 billion, exceeding the Zacks consensus estimate. Non-COVID revenue growth and sales from newly launched and acquired products drove the quarterly beat. Core-business revenue declined 2% as COVID-19 product demand weakened and patent expirations pressured sales. Pfizer’s 2026 revenue guidance was increased, but the company still expects full-year revenue to decline from 2025 levels.

Key facts

• Pfizer's corporate messaging shift to AI-driven R&D coincided with a 2% decline in its core business revenue. source
• Pfizer's recent second-quarter results exceeded expectations, driven by non-COVID revenue growth and sales from new and acquired products. source